Did you know that no study has been done on the impact of the reform on the life sciences ecosystem? Did you know? That is my question. I gather that the answer is no.
We are in favour of reducing the price of medications and we want people to pay a fair price for their medications. But it seems more complex.
According to the testimony from patients' groups, from members of the industry and from researchers in various areas, the reform has a flaw. Everyone agrees that the basis of comparison has to be changed. According to the briefs we have received, that would allow the price of medications to be reduced by 20 to 30%, just as a start. Then, the only thing left would be to find points of commonality.
Are you going to apply that progressively, starting on June 1, by focusing on the service baskets? Then, people will have to be brought together to find the best possible solutions to ensure that patients, our children, will be able to get novel medications that could save their lives.